PEGylated nanoparticles interact with macrophages independently of immune response factors and trigger a non-phagocytic, low-inflammatory response-Reference-Cited by-同舟云学术

PEGylated nanoparticles interact with macrophages independently of immune response factors and trigger a non-phagocytic, low-inflammatory response

Published:2024-02 Issue: Volume:366 Page:282-296
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Asoudeh Monireh,Nguyen Nicole,Raith Mitch,Denman Desiree S.,Anozie Uche C.,Mokhtarnejad Mahshid,Khomami Bamin,Skotty Kaitlyn M.,Isaac Sami,Gebhart Taylor,Vaigneur Lauren,Gelgie Aga,Dego Oudessa Kerro,Freeman Trevor,Beever Jon,Dalhaimer Paul

Funder

National Institute of Environmental Health Sciences

National Institutes of Health

National Institute of General Medical Sciences

Publisher

Elsevier BV

Reference45 articles.

1. Elongated PEG-based nanoparticles bind the high-density lipoprotein (HDL) receptor scavenger receptor class B I (SR-BI);Raith;J. Control. Release,2021

2. Impact of anti-PEG antibodies induced by SARS-CoV-2 mRNA vaccines;Ju;Nat. Rev. Immunol.,2023

3. Nanoparticle entry into cells; the cell biology weak link;Griffiths;Adv. Drug Deliv. Rev.,2022

4. Scavenger receptor class B type I is a multiligand HDL receptor that influences diverse physiological systems;Krieger;J. Clin. Investig.,2001

5. Time-evolution of in vivo protein corona onto blood-circulating PEGylated liposomal doxorubicin (DOXIL) nanoparticles;Hadjidemetriou;Nanoscale,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Entry of nanoparticles into cells and tissues: status and challenges;Beilstein Journal of Nanotechnology;2024-08-12

2. Age-dependent changes in phagocytic activity: in vivo response of mouse pulmonary antigen presenting cells to direct lung delivery of charged PEGDA nanoparticles;Journal of Nanobiotechnology;2024-08-12

3. Understanding nanoparticle-liver interactions in nanomedicine;Expert Opinion on Drug Delivery;2024-06-02